As the most common type of non-cancerous tumors in women of reproductive age, uterine fibroids can cause physical symptoms, including heavy menstrual bleeding. Additionally, uterine fibroids can take a significant toll on quality of life, relationships and intimacy, employment, and create an overall reduced quality of well-being in a patient’s health. Dr. Veronica Gillispie-Bell, Senior Site Lead and Section Head of Obstetrics and Gynecology at Ochsner Kenner in New Orleans discusses heavy menstrual bleeding as a symptom of uterine fibroids, options in the treatment landscape, including ORIAHNN™, the first, non-surgical, oral medication developed specifically to treat heavy menstrual bleeding associated with uterine fibroids in premenopausal patients. She also shares how HCPs can open a dialogue with patients about their individual symptoms, lifestyle and treatment goals, and to address their concerns sooner rather than later.
Veronica Gillispie-Bell, MD, MS, is a practicing ob-gyn and section head of women’s services at Ochsner Kenner in New Orleans. She is the Medical Director of the Louisiana Perinatal Quality Collaborative (LaPQC) and Pregnancy Associated Mortality Review with the LA Department of Health. She is an associate professor and director of the Center for Minimally Invasive Treatment of Uterine Fibroids.
Dr. Veronica Gillispie-Bell is a Board-Certified Obstetrician & Gynecologist and Associate Professor for Ochsner Health in New Orleans, Louisiana. She serves as the Senior Site Lead and Section Head of Obstetrics and Gynecology at Ochsner Kenner. Additionally, she serves as the Director of Quality for Women’s Services for the Ochsner Health System and is an associate professor and director of the Center for Minimally Invasive Treatment of Uterine Fibroids. Dr. Gillispie-Bell is also the Medical Director of the Louisiana Perinatal Quality Collaborative and Pregnancy Associated Mortality Review for the Louisiana Department of Health.
She earned her medical degree from Meharry Medical College and completed her residency training at Ochsner Health System. She also earned a Master of Applied Science in Patient Safety and Healthcare Quality from the Johns Hopkins Bloomberg School of Public Health. Additionally, she has received certification in Diversity and Inclusion from Cornell University